Health & Beauty

Physical activity may lessen glaucoma risk

The FINANCIAL-- If Americans needed another reason to get up and get active, it's this: Physical activity, even just the bare minimum, may lessen glaucoma risk and its threat of vision loss, research ...

Update on TULIP 1 Phase III trial for anifrolumab

The FINANCIAL -- AstraZeneca and MedImmune, its global biologics research and development arm, announced top-line results from the TULIP 1 Phase III trial for anifrolumab in adult patients with ...

When T-cells go bad

The FINANCIAL -- Glaucomatous neurodegeneration may stem from a case of mistaken identities after high intraocular pressure (IOP) triggers an autoimmune response that targets retinal cells, new ...

Novartis combination therapy Tafinlar + Mekinist for adjuvant treatment of BRAF V600 mutation-positive melanoma

The FINANCIAL -- Basel, August 29, 2018 - Novartis announced that the European Commission (EC) has approved Tafinlar (dabrafenib) in combination with Mekinist (trametinib) for the adjuvant treatment ...

Christopher Boerner Appointed as Executive Vice President and Chief Commercial Officer in Bristol-Myers Squibb

The FINANCIAL -- PRINCETON, N.J.-- Bristol-Myers Squibb Company announced that Christopher Boerner, Ph.D., has been appointed executive vice president and chief commercial officer, effective ...

Treatment Of Patients With Severe Asthma Without An Eosinophilic Phenotype

The FINANCIAL -- THOUSAND OAKS, Calif.,-- Amgen and AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for tezepelumab in patients ...

$65,500 to children’s vision projects

The FINANCIAL -- An estimated 32,500 children in 11 states from California to New York will benefit from the Healthy Eyes Healthy Children Community Grants (HEHC) program. HEHC, in its second year, ...

£1m for epilepsy research

The FINANCIAL -- University of Liverpool scientists have been boosted £1m by the Medical Research Council to research the brain mechanisms contributing to cognitive problems and treatment outcome ...

Number of adults over 85 needing 24-hour care

The FINANCIAL -- The number of adults aged 85 plus needing round-the-clock care in England will almost double to 446,000 over the next 20 years, according to new research from the LSE-led MODEM ...

Boehringer Ingelheim supports BeiGene in serving patients worldwide with tislelizumab development

The FINANCIAL -- Shanghai, China, September 3rd, 2018 – BeiGene Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and ...

Practical tips when disaster strikes

The FINANCIAL -- Amid raging wildfires in California, and as it is entered what the National Oceanic and Atmospheric Administration calls the most active and dangerous time of year for tropical ...

Other

User pages

Main Menu

Physical activity may lessen glaucoma risk

Update on TULIP 1 Phase III trial for anifrolumab

When T-cells go bad

Novartis combination therapy Tafinlar + Mekinist for adjuvant treatment of BRAF V600 mutation-positive melanoma

Christopher Boerner Appointed as Executive Vice President and Chief Commercial Officer in Bristol-Myers Squibb

Treatment Of Patients With Severe Asthma Without An Eosinophilic Phenotype

$65,500 to children’s vision projects

£1m for epilepsy research

Number of adults over 85 needing 24-hour care

Boehringer Ingelheim supports BeiGene in serving patients worldwide with tislelizumab development

Practical tips when disaster strikes

Get in Touch

Resource

Guidebook

Follow us

Terms